SG Americas Securities’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$296K Buy
18,256
+3,747
+26% +$66.3K ﹤0.01% 2462
2025
Q4
$271K Buy
14,509
+7,571
+109% +$126K ﹤0.01% 2804
2025
Q3
$101K Buy
+6,938
New +$87.7K ﹤0.01% 3081
2025
Q2
Sell
-21,557
Closed -$193K 3579
2025
Q1
$193K Buy
21,557
+2,355
+12% +$21.9K ﹤0.01% 2559
2024
Q4
$181K Buy
19,202
+3,349
+21% +$30.5K ﹤0.01% 2248
2024
Q3
$128K Sell
15,853
-146,535
-90% -$1.27M ﹤0.01% 2858
2024
Q2
$1.38M Sell
162,388
-47,178
-23% -$426K 0.01% 1143
2024
Q1
$1.88M Buy
209,566
+12,460
+6% +$115K 0.01% 888
2023
Q4
$2.21M Sell
197,106
-55,503
-22% -$559K 0.02% 637
2023
Q3
$2.18M Buy
252,609
+101,475
+67% +$980K 0.03% 670
2023
Q2
$1.56M Buy
151,134
+121,126
+404% +$1.34M 0.01% 856
2023
Q1
$326K Buy
30,008
+14,601
+95% +$154K ﹤0.01% 2067
2022
Q4
$173K Sell
15,407
-11,858
-43% -$125K ﹤0.01% 2302
2022
Q3
$276K Buy
27,265
+9,567
+54% +$89.6K ﹤0.01% 2058
2022
Q2
$160K Buy
+17,698
New +$163K ﹤0.01% 2823
2022
Q1
Sell
-21,711
Closed -$240K 3420
2021
Q4
$240K Sell
21,711
-17,257
-44% -$150K ﹤0.01% 2574
2021
Q3
$288K Buy
38,968
+30,926
+385% +$346K ﹤0.01% 2980
2021
Q2
$117K Buy
+8,042
New +$151K ﹤0.01% 2578
2021
Q1
Sell
-42,230
Closed -$750K 3555
2020
Q4
$750K Buy
+42,230
New +$758K 0.01% 1707
2020
Q3
Sell
-16,643
Closed -$349K 3432
2020
Q2
$349K Sell
16,643
-11,535
-41% -$296K ﹤0.01% 2407
2020
Q1
$651K Buy
28,178
+22,143
+367% +$554K 0.01% 1617
2019
Q4
$156K Buy
+6,035
New +$117K ﹤0.01% 2663
2019
Q2
Sell
-6,890
Closed -$156K 3414
2019
Q1
$156K Buy
+6,890
New +$175K ﹤0.01% 2744
2018
Q2
Sell
-5,347
Closed -$130K 3549
2018
Q1
$130K Buy
+5,347
New +$147K ﹤0.01% 2743
2017
Q4
Sell
-9,061
Closed -$310K 3622
2017
Q3
$310K Buy
9,061
+3,130
+53% +$102K ﹤0.01% 2202
2017
Q2
$236K Buy
5,931
+443
+8% +$17K ﹤0.01% 2304
2017
Q1
$202K Sell
5,488
-16,022
-74% -$512K ﹤0.01% 2431
2016
Q4
$686K Buy
+21,510
New +$667K 0.01% 1514

Other funds holding TBPH